<div class="container">
    <div class="row">
        <div id="speaker-detail" class="col-lg-6 col-lg-offset-3">
            <div class="row">
                <button title="Close (Esc)" type="button" class="mfp-close">×</button>
                <div class="col-md-4 col-lg-4">
                    <img class="img-responsive" src="img/speaker_401.png" alt="" />
                    <br />
                </div>
                <div class="col-md-8 col-lg-8">
                    <h2>Charley Lu, MS, MBA, 呂全偉 經理</h2>
                    <h3>Senior Business Development Manager</h3>
                    <p>Mr. Lu is currently the Senior Business Development Manager at Taiwan Liposome Company (TLC), a publicly listed specialty biopharmaceutical company focusing on lipid-based nanoparticles drug delivery technologies. He leads business development and alliance management activities. Previously, Mr Lu served as the Principal of Strategic Initiatives at Carantech, Inc. Carantech was a spinout from the University of California, San Francisco developing neuroprotective therapies for Multiple Sclerosis patients.  Mr Lu shared fundraising and operating responsibilities with the founding team.
                    </p>
 
                    <p>Mr. Lu is a member of Mayor’s Biotech Advisory Council in San Francisco. He earned his MBA from the Johnson School at Cornell University focusing on venture capital and private equity and his MS from Northwestern University studying bioinformatics and immunology. Prior to Cornell and Northwestern, Mr. Lu independently led autoimmune disease research at the University of California, San Francisco Medical Center while earning his BA in Integrative Biology with emphasis in Neurobiology and Endocrinology from the University of California, Berkeley. He was the award winner at Cornell’s Big Idea Business Plan competition and the Jonas Weil Entrepreneurship Fellow.
                    </p>
 
                    <p>Mr. Lu is an active and recognized leader in the community. He has received multiple commendations for his public outreach, fundraising, and volunteering efforts at the Greater Bay Area Make-A-Wish Foundation granting wishes to children with life-threatening illnesses.
                    </p>
                    <p>Jenny Chen focuses her practice on U.S. and foreign patent prosecution, freedom-to-operate and invalidity opinion work, due diligence studies, post-grant challenges, and counseling clients in the areas of biological, medical, and pharmaceutical sciences. She is currently an Associate at Wolf Greenfield. Jenny has worked on projects related to diagnosis and treatment of various diseases and disorders, vaccine technologies, drug discovery, antibiotic biosynthesis, biosimilars, medical implants, gene- and cell-based therapies, pharmaceutical formulations, and herb extracts. She was named to the 2014 list of Massachusetts Rising Stars by Super Lawyers, an honor reserved for those lawyers who exhibit excellence in practice. </p>
                    <p>Jenny received her J.D. from Northeastern University School of Law. She is a member of the State Bar of Massachusetts and is registered to practice before the U.S. Patent and Trademark Office. She is a member of the American Intellectual Property Law Association and Boston Patent Law Association. Jenny received her Ph.D. from Baylor College of Medicine and her B.S. from Fudan University.
                    </p>
                </div>
            </div>
        </div>
    </div>
</div>
